Training Program in Immunological Tolerance and Autoimmunity

免疫耐受和自身免疫培训计划

基本信息

  • 批准号:
    9264976
  • 负责人:
  • 金额:
    $ 18.95万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-07-01 至 2020-06-30
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): The goal of the Graduate Training Program in Autoimmunity and Tolerance at Harvard Medical School is to recruit students of exceptional ability regardless of gender or ethnicity and provide these students with the best attainable training environment in which they may develop into independently thinking scientists, specializing in the field of immunology. The focus of their research will be relevant to the basic understanding of the underlying mechanisms of autoimmunity and aspects of immunobiology relevant to the therapy of autoimmune and chronic inflammatory diseases. This goal will be accomplished through formal course-work, laboratory rotations, literature discussions, discussions with faculty and mentored research. Students may choose from 46 faculty members for rotations and laboratory work in all major areas of immunology that are of relevance to autoimmunity. Policies and guidelines for graduate work are set by the Graduate Committee, a body of senior and junior faculty active in the teaching immunology program, in accordance with the Executive Committee in Immunology and those of the Division of Medical Sciences. Students' progress is monitored through the administration of a comprehensive qualifying examination, comprised of an oral presentation and a written proposal (NIH style post-doctoral application). This phase of the student's training -including coursework and rotations- is usually completed by the middle of the second year. Dissertation research is supervised by the dissertation advisor and its progress is monitored by a dissertation advisory committee. The experimental component usually requires 3-4 years to complete a body of work considered adequate for a written dissertation.
 描述(由申请人提供):哈佛医学院自身免疫和耐受研究生培训项目的目标是招收具有特殊能力的学生,无论性别或种族,并为这些学生提供最佳的培训环境,使他们能够发展成为独立思考的科学家,专门从事免疫学领域。他们的研究重点将涉及对自身免疫潜在机制的基本理解以及与自身免疫和慢性炎症性疾病治疗相关的免疫生物学方面。这一目标将通过正式的课程作业、实验室轮换、文献讨论、与教师的讨论和指导研究来实现。学生可以从 46 名教职人员中进行选择,在与自身免疫相关的免疫学所有主要领域进行轮换和实验室工作。研究生工作的政策和指南由研究生委员会制定,该委员会是一个由活跃于免疫学教学项目的高级和初级教师组成的机构,根据免疫学执行委员会和医学科学部的执行委员会的规定。通过全面的资格考试来监控学生的进步,考试包括口头陈述和书面提案(NIH 风格的博士后申请)。学生培训的这一阶段(包括课程作业和轮换)通常在第二年中期完成。论文研究由论文导师监督,其进展由论文咨询委员会监督。实验部分通常需要 3-4 年才能完成足以撰写论文的工作。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SHIV Subramaniam PILLAI其他文献

SHIV Subramaniam PILLAI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SHIV Subramaniam PILLAI', 18)}}的其他基金

Training Program in Immunological Tolerance and Autoimmunity
免疫耐受和自身免疫培训计划
  • 批准号:
    9102896
  • 财政年份:
    2015
  • 资助金额:
    $ 18.95万
  • 项目类别:
Training Program in Immunological Tolerance and Autoimmunity
免疫耐受和自身免疫培训计划
  • 批准号:
    8933644
  • 财政年份:
    2015
  • 资助金额:
    $ 18.95万
  • 项目类别:
An Autoimmune center of excellence for the study of IgG4-related disease
研究 IgG4 相关疾病的自身免疫卓越中心
  • 批准号:
    8680709
  • 财政年份:
    2014
  • 资助金额:
    $ 18.95万
  • 项目类别:
Coordinating an ACE studying IgG4-related diseases
协调 ACE 研究 IgG4 相关疾病
  • 批准号:
    10188398
  • 财政年份:
    2014
  • 资助金额:
    $ 18.95万
  • 项目类别:
Admin-Core-001
管理核心-001
  • 批准号:
    10794460
  • 财政年份:
    2014
  • 资助金额:
    $ 18.95万
  • 项目类别:
An autoimmune center of excellence for the study of IgG4-related disease
研究 IgG4 相关疾病的自身免疫卓越中心
  • 批准号:
    9915860
  • 财政年份:
    2014
  • 资助金额:
    $ 18.95万
  • 项目类别:
Studies on the Immunology of IgG4-related diseases
IgG4相关疾病的免疫学研究
  • 批准号:
    8732923
  • 财政年份:
    2014
  • 资助金额:
    $ 18.95万
  • 项目类别:
Coordinating an ACE studying IgG4-related diseases
协调 ACE 研究 IgG4 相关疾病
  • 批准号:
    10394915
  • 财政年份:
    2014
  • 资助金额:
    $ 18.95万
  • 项目类别:
An autoimmune center of excellence for the study of IgG4-related disease
研究 IgG4 相关疾病的自身免疫卓越中心
  • 批准号:
    10188397
  • 财政年份:
    2014
  • 资助金额:
    $ 18.95万
  • 项目类别:
An autoimmune center of excellence for the study of IgG4-related disease
研究 IgG4 相关疾病的自身免疫卓越中心
  • 批准号:
    10394914
  • 财政年份:
    2014
  • 资助金额:
    $ 18.95万
  • 项目类别:

相似海外基金

Nucleic acid stimulation-induced mechanism to overcome MDSC-mediated immune tolerance in tumor microenvironment
核酸刺激诱导机制克服肿瘤微环境中MDSC介导的免疫耐受
  • 批准号:
    24K18539
  • 财政年份:
    2024
  • 资助金额:
    $ 18.95万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mechanisms of Il-2-mediated immune tolerance
IL-2介导的免疫耐受机制
  • 批准号:
    10608299
  • 财政年份:
    2023
  • 资助金额:
    $ 18.95万
  • 项目类别:
The amplification mechanism of bovine maternal immune tolerance for conce
牛母体免疫耐受的放大机制
  • 批准号:
    23H02356
  • 财政年份:
    2023
  • 资助金额:
    $ 18.95万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The role of B cell - macrophage interactions for adaption to virus escape, memory, and immune tolerance
B 细胞-巨噬细胞相互作用在适应病毒逃逸、记忆和免疫耐受中的作用
  • 批准号:
    BB/X017281/1
  • 财政年份:
    2023
  • 资助金额:
    $ 18.95万
  • 项目类别:
    Research Grant
Oral nanoparticle formulations for allergy treatment via efficient induction of immune tolerance
通过有效诱导免疫耐受来治疗过敏的口服纳米颗粒制剂
  • 批准号:
    22KJ2442
  • 财政年份:
    2023
  • 资助金额:
    $ 18.95万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Polymer-derived biomaterials for mRNA delivery to induce antigen-specific immune tolerance
用于 mRNA 递送以诱导抗原特异性免疫耐受的聚合物衍生生物材料
  • 批准号:
    10886168
  • 财政年份:
    2023
  • 资助金额:
    $ 18.95万
  • 项目类别:
Regulation of mast cell activation and immune tolerance by food-related factors focusing on short-chain fatty acid
以短链脂肪酸为重点的食物相关因子对肥大细胞活化和免疫耐受的调节
  • 批准号:
    23H02167
  • 财政年份:
    2023
  • 资助金额:
    $ 18.95万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Diversity Supplement: Placenta-specific miR-519c-mediated induction of immune tolerance in human placenta - Revision - 1
多样性补充:胎盘特异性 miR-519c 介导的人胎盘免疫耐受诱导 - 修订版 - 1
  • 批准号:
    10833899
  • 财政年份:
    2023
  • 资助金额:
    $ 18.95万
  • 项目类别:
Allograft inflammatory factor-1 and immune tolerance
同种异体移植物炎症因子-1和免疫耐受
  • 批准号:
    10511362
  • 财政年份:
    2022
  • 资助金额:
    $ 18.95万
  • 项目类别:
Evaluation of a beta cell replacement therapy combined product that avoids the need for immunosuppression via localized induction of immune tolerance
评估通过局部诱导免疫耐受而无需免疫抑制的 β 细胞替代疗法组合产品
  • 批准号:
    10603016
  • 财政年份:
    2022
  • 资助金额:
    $ 18.95万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了